Allient CEO-linked trusts sell 70K shares, gift 10K

Trusts associated with Allient Inc. CEO Richard S. Warzala reported open-market sales of an aggregate 70,000 shares of Common Stock on August 10, 2026, at weighted average prices within disclosed ranges between $112.49 and $115.765.

Rhea-AI Filing Summary

Trusts associated with Allient Inc. CEO Richard S. Warzala reported open-market sales of an aggregate 70,000 shares of Common Stock on August 10, 2026, at weighted average prices within disclosed ranges between $112.49 and $115.765. The footnotes state these shares were sold by trusts benefiting members of his immediate family for which he serves as trustee. On the same date, he also made a bona fide gift of 10,000 shares to the Warzala Family Charitable Fund. A separate entry shows 26,067 shares held indirectly through an ESOP trust after the reported transactions.

Insider Trade Summary

Net Seller: 70,000 shares

Net Sell 6 txns

Insider WARZALA RICHARD S

Role Chief Executive Officer

Sold 70,000 shs ($7.95M)

Type	Security	Shares	Price	Value
Sale	Common Stock F1, F2	17,028	$112.8144	$1.92M
Sale	Common Stock F1, F3	18,176	$113.5167	$2.06M
Sale	Common Stock F1, F4	33,944	$113.9591	$3.87M
Sale	Common Stock F1, F5	852	$115.3501	$98K
Gift	Common Stock F6	10,000	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 1,489,106 shares (Direct); Common Stock — 26,067 shares (Indirect, By ESOP Trust)

Footnotes (6)

1. F1. Shares sold by trusts for the benefit of members of the Reporting Person's immediate family and for which the Reporting Person serves as trustee.
2. F2. These shares were sold in multiple transactions at prices ranging from $112.49 to $112.99, inclusive.
3. F3. These shares were sold in multiple transactions at prices ranging from $113.015 to $113.695, inclusive.
4. F4. These shares were sold in multiple transactions at prices ranging from $113.70 to $114.69, inclusive.
5. F5. These shares were sold in multiple transactions at prices ranging from $114.95 to $115.765, inclusive.
6. F6. The reported disposition represents a bona fide gift by the Reporting Person to the Warzala Family Charitable Fund, a charitable fund established by the Reporting Person.

Key Figures

Shares sold: 70,000 shares Sale price ranges: $112.49–$115.765 per share Shares gifted: 10,000 shares +2 more

5 metrics

Shares sold 70,000 shares Common Stock sold in open-market transactions on August 10, 2026

Sale price ranges $112.49–$115.765 per share Price ranges for multiple sale transactions as disclosed in footnotes

Shares gifted 10,000 shares Bona fide gift to the Warzala Family Charitable Fund on August 10, 2026

Indirect ESOP holdings 26,067 shares Common Stock held indirectly “By ESOP Trust” after the reported transactions

Net buy/sell direction Net-sell of 70,000 shares Aggregate of reported buy/sell transactions in this Form 4

Key Terms

weighted average price, bona fide gift, ESOP Trust, immediate family

4 terms

weighted average price financial

"Each price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

bona fide gift financial

"The reported disposition represents a bona fide gift by the Reporting Person"

A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.

ESOP Trust financial

"total_shares_following_transaction 26067.0000, nature_of_ownership By ESOP Trust"

immediate family financial

"Shares sold by trusts for the benefit of members of the Reporting Person's immediate family"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Allient Inc. (ALNT) disclose for August 10, 2026?

Allient Inc. reported that trusts associated with CEO Richard S. Warzala sold 70,000 common shares in open-market transactions and that he made a bona fide gift of 10,000 shares to the Warzala Family Charitable Fund on August 10, 2026.

Who actually sold the 70,000 Allient Inc. (ALNT) shares in this Form 4?

The filing explains that the 70,000 shares were sold by trusts for the benefit of members of Richard S. Warzala’s immediate family, for which he serves as trustee, rather than direct individual sales from his personal holdings.

At what prices were the Allient Inc. (ALNT) shares sold in the August 10, 2026 transactions?

The 70,000 Allient common shares were sold in multiple transactions at weighted average prices, with price ranges disclosed between $112.49 and $115.765 per share, depending on the specific trade group described in the footnotes.

What gift of Allient Inc. (ALNT) shares did CEO Richard S. Warzala report?

Richard S. Warzala reported a bona fide gift of 10,000 Allient common shares to the Warzala Family Charitable Fund, a charitable fund he established, as a non-cash disposition separate from the open-market sales reported the same day.

How many Allient Inc. (ALNT) shares does Richard S. Warzala hold indirectly through an ESOP trust?

The Form 4 indicates that, in a separate holding entry, 26,067 shares of Allient common stock are held indirectly “By ESOP Trust” after the reported transactions, reflecting an indirect ownership position through that employee stock ownership structure.

Were the reported Allient Inc. (ALNT) insider sales made under a Rule 10b5-1 trading plan?

The filing’s Rule 10b5-1 checkbox is not checked, and there is no footnote indicating a pre-arranged trading plan, so the transactions are not identified in the document as being executed under a Rule 10b5-1 plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/12/2026 - 05:27 PM Accepted by SEC EDGAR 08/12/2026 - 05:26 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WARZALA RICHARD S

(Last) (First) (Middle)

ALLIENT INC.

6400 MAIN STREET, SUITE 150

(Street)

WILLIAMSVILLE NEW YORK 14221

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ALLIENT INC [ ALNT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/10/2026		S(1)		17,028	D	$112.8144(2)	1,552,078	D
Common Stock	08/10/2026		S(1)		18,176	D	$113.5167(3)	1,533,902	D
Common Stock	08/10/2026		S(1)		33,944	D	$113.9591(4)	1,499,958	D
Common Stock	08/10/2026		S(1)		852	D	$115.3501(5)	1,499,106	D
Common Stock	08/10/2026		G		10,000	D	(6)	1,489,106	D
Common Stock								26,067	I	By ESOP Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares sold by trusts for the benefit of members of the Reporting Person's immediate family and for which the Reporting Person serves as trustee.

2. These shares were sold in multiple transactions at prices ranging from $112.49 to $112.99, inclusive.

3. These shares were sold in multiple transactions at prices ranging from $113.015 to $113.695, inclusive.

4. These shares were sold in multiple transactions at prices ranging from $113.70 to $114.69, inclusive.

5. These shares were sold in multiple transactions at prices ranging from $114.95 to $115.765, inclusive.

6. The reported disposition represents a bona fide gift by the Reporting Person to the Warzala Family Charitable Fund, a charitable fund established by the Reporting Person.

Remarks:

Each price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Allient Inc., any security holder of Allient Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4.

	/s/ Michael C. Donlon, Attorney-in-Fact for Richard S. Warzala	08/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)